Skip to main content
. 2023 Jun 29;28(13):5081. doi: 10.3390/molecules28135081

Table 1.

Clinical trials with the use of mesalazine in the chemoprevention of diseases related to the large intestine.

Study Title ClinicalTrials.gov Identifier Phase Status Enrollment
Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an “in Vivo” Evaluation of the Molecular Effects on β-catenin Signaling Pathway NCT02077777 II Completed 21
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (MesaCAPP) NCT03070574 II Terminated 8
Mesalazine Effects in Sporadic Colorectal Adenoma Patients NCT01894685 II Completed 74
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (MesaCAPP) NCT04920149 II Recruiting 260